Ramucirumab Plus TAS-102 in Patients With Advanced or Metastatic Gastric Adenocarcinoma or the Gastroesophageal Junction
Clinical trial NCT04517747 · COMPLETED
Trial details
- NCT number
- NCT04517747
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2022-01-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.